Gastrointestinal Cancer Clinical Trials & Research at Providence Medical Group

Providence Medical Group is currently enrolling patients for the following gastrointestinal cancer clinical trials:

Gastric Cancer
Colorectal Cancer


Tucatinib Plus Trastuzumab in Patients with HER2+ Colorectal Cancer

Treatment agent: Tucatinib + Trastuzumab
PI: Ian Anderson, MD
Study Coordinator: Teresa Lund // Teresa.Lund@stjoe.org // (707) 521-3803 ext. 1103
Resources and Links: https://clinicaltrials.gov/ct2/show/NCT03043313


Our Providers

Our Provider

Ana E Espitia, NP
Ana E Espitia, NP
Gastroenterology
City:  Napa
4.7 out of 5

Meet Our Program Director

Our Providers

Humboldt Providers

Our Humboldt Provider

Sharkeiya Toinakai Terrell, FNP
Sharkeiya Toinakai Terrell, FNP
Gastroenterology
City:  Eureka

Sonoma and Napa Providers

Our Sonoma and Napa Provider

Ana E Espitia, NP
Ana E Espitia, NP
Gastroenterology
City:  Napa
4.7 out of 5

Our Locations